Cargando…

Proton Pump Inhibitor Use Is Not Strongly Associated With SARS-CoV-2 Related Outcomes: A Nationwide Study and Meta-analysis

BACKGROUND & AIMS: Proton pump inhibitor (PPI) use has been associated with increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and severe outcomes. However, meta-analyses show unclear results, leading to uncertainty regarding the safety of PPI use during the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Israelsen, Simone Bastrup, Ernst, Martin Thomsen, Lundh, Andreas, Lundbo, Lene Fogt, Sandholdt, Håkon, Hallas, Jesper, Benfield, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the AGA Institute. Published by Elsevier Inc. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111907/ https://www.ncbi.nlm.nih.gov/pubmed/33989790 http://dx.doi.org/10.1016/j.cgh.2021.05.011

Ejemplares similares

Reply
por: Israelsen, Simone Bastrup, et al.
Publicado: (2022)

Nonspecific symptoms dominate at first contact to emergency healthcare services among cases with invasive meningococcal disease
por: Hovmand, Nichlas, et al.
Publicado: (2021)

Prediction of Respiratory Failure and Mortality in COVID-19 Patients Using Long Pentraxin PTX3
por: Hansen, Cecilie Bo, et al.
Publicado: (2022)

Increased Risk of Invasive Meningococcal Disease Associated with Primary and Secondary Immunodeficiency
por: Lundbo, Lene Fogt, et al.
Publicado: (2017)

Factors associated with treatment delay and outcome in community acquired bacterial meningitis
por: Hovmand, Nichlas, et al.
Publicado: (2023)

Use of proton pump inhibitors after antireflux surgery: a nationwide register-based follow-up study
por: Lødrup, Anders, et al.
Publicado: (2014)

Proton pump inhibitor-induced subacute cutaneous lupus erythematosus
por: Sandholdt, LH, et al.
Publicado: (2014)

The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection
por: Ward, Daniel, et al.
Publicado: (2022)

241. Early switch from intravenous to oral antibiotics in patients with Gram-negative bacteremia – a target trial emulation
por: Tingsgård, Sandra, et al.
Publicado: (2023)

Influence of Hepatitis C Virus and IL28B Genotypes on Liver Stiffness
por: Lundbo, Lene Fogt, et al.
Publicado: (2014)

581. Impact of Urinary Antigen Tests on Clinical Outcomes in Patients Hospitalized with Community-acquired Pneumonia
por: Kern, Marita, et al.
Publicado: (2023)

The Association of Low Vitamin K Status with Mortality in a Cohort of 138 Hospitalized Patients with COVID-19
por: Linneberg, Allan, et al.
Publicado: (2021)

Increased risk of incident primary cancer after Staphylococcus aureus bacteremia: A matched cohort study
por: Gotland, Nanja, et al.
Publicado: (2020)

Circulating Adiponectin Levels Are Inversely Associated with Mortality and Respiratory Failure in Patients Hospitalized with COVID-19
por: Hindsberger, Bettina, et al.
Publicado: (2023)

Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden
por: Brusselaers, Nele, et al.
Publicado: (2017)

Proton-pump inhibitors among adults: a nationwide drug-utilization study
por: Hálfdánarson, Óskar Ö., et al.
Publicado: (2018)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Short-course antibiotic therapy of 5 days in community-acquired pneumonia (CAP5): study protocol for a randomised controlled trial
por: Israelsen, Simone Bastrup, et al.
Publicado: (2023)

Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products and risk of cancer: Danish nationwide cohort study
por: Pottegård, Anton, et al.
Publicado: (2018)

Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study
por: Lin, Sheng-Hong, et al.
Publicado: (2021)

Proton pump inhibitor use and risk of depression and anxiety in children: nationwide cohort study
por: Wang, Yun‐Han, et al.
Publicado: (2022)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds
por: Komen, Joris, et al.
Publicado: (2022)

Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Bigseth, Robert Strengen, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Proton Pump Inhibitor Use Increases Pyogenic Liver Abscess Risk: A Nationwide Cohort Study
por: Oh, Joo Hyun, et al.
Publicado: (2021)

Proton pump inhibitor use and the risk for Parkinson’s disease: A nationwide population-based study in Taiwan
por: Chen, Huan-Lin, et al.
Publicado: (2023)

Discussing proton pump inhibitor deprescribing: the views of Danish GPs and older patients
por: Thompson, Wade, et al.
Publicado: (2020)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

Short course antibiotic treatment of Gram-negative bacteraemia (GNB5): a study protocol for a randomised controlled trial
por: Tingsgård, Sandra, et al.
Publicado: (2023)

Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors
por: Janett, Simone, et al.
Publicado: (2015)

Management of laryngopharyngeal reflux with proton pump inhibitors
por: Reimer, Christina, et al.
Publicado: (2008)

Proton Pump Inhibitor Induced Depigmentation in Vitiligo
por: Holla, Anantha Prasad, et al.
Publicado: (2011)

Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism
por: Swaminathan, Krishnan
Publicado: (2015)

Proton pump inhibitors: A balanced view
por: Ramakrishna, B.S.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ghkkcfj9b8b54li6fgmja6njuc